BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
BIOXYTRAN, INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026
- Market cap
- $2.56M
- P/E (TTM)
- –
- Dividend yield
- –
Bioxytran statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Bioxytran | Industry median |
|---|---|---|
| Market Cap | $2.57M | $164.85M |
| Enterprise Value | $2.39M | $87.06M |
Income (trailing twelve months)
| Measure | Bioxytran | Industry median |
|---|---|---|
| Operating Income | -$3.69M | -$21.44M |
| Pretax Income | -$3.49M | -$14.45M |
| Net Income | -$3.49M | -$22.46M |
| EBITDA | -$3.69M | -$16.91M |
| EPS (Diluted) | -$0.04 | -$0.83 |
Returns
| Measure | Bioxytran | Industry median |
|---|---|---|
| Return on Assets (ROA) | -1453.0% | -41.0% |
Balance sheet
| Measure | Bioxytran | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $177.38K | $62.42M |
| Net Cash (Debt) | $177.38K | $15.68M |
| Net Cash Per Share | $0.00 | $0.66 |
| Equity (Book Value) | -$4.94M | $48.79M |
| Book Value Per Share | -$0.04 | $1.36 |
| Tangible Book Value | -$5.10M | $23.06M |
| Working Capital | -$5.10M | $75.77M |
Financial position
| Measure | Bioxytran | Industry median |
|---|---|---|
| Current Ratio | 0.03 | 3.30 |
| Quick Ratio | 0.03 | 2.39 |
| Interest Coverage | -25.47 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Bioxytran | Industry median |
|---|---|---|
| Operating Cash Flow | -$874.32K | -$12.35M |
Efficiency
| Measure | Bioxytran | Industry median |
|---|---|---|
| Profits Per Employee | -$873.45K | -$703.34K |
| Employee Count | 4 | 74 |
Dividends and yields
| Measure | Bioxytran | Industry median |
|---|---|---|
| Earnings Yield | -136.1% | -22.7% |
Shares
| Measure | Bioxytran | Industry median |
|---|---|---|
| Shares Outstanding | 114,695,000 | 58,179,650 |
| Shares Change (YoY) | 4.83% | 11.1% |
| Shares Change (QoQ) | 1.18% | 0.54% |
| Float | 71,299,700 | 49,173,100 |
| Shares Held by Insiders | 37.8% | 11.6% |
Scores
| Measure | Bioxytran | Industry median |
|---|---|---|
| Altman Z-Score | -154.25 | -0.24 |
| Piotroski F-Score | 5 | 4 |
Calculated by StockData from Bioxytran's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.